173 related articles for article (PubMed ID: 10948322)
1. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
2. Induction of MHC antigens by tumour cell lines in response to interferons.
Nouri AM; Hussain RF; Dos Santos AV; Gillott DJ; Oliver RT
Eur J Cancer; 1992; 28A(6-7):1110-5. PubMed ID: 1378291
[TBL] [Abstract][Full Text] [Related]
3. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
Panelli MC; Wang E; Shen S; Schluter SF; Bernstein RM; Hersh EM; Stopeck A; Gangavalli R; Barber J; Jolly D; Akporiaye ET
Cancer Immunol Immunother; 1996 Feb; 42(2):99-107. PubMed ID: 8620527
[TBL] [Abstract][Full Text] [Related]
5. The expression of MHC antigens on cultured oral keratinocytes and relationship to malignancy.
Crane IJ; Rice SQ; Luker J; de Gay L; Scully C; Prime SS
Br J Exp Pathol; 1988 Oct; 69(5):749-58. PubMed ID: 2461729
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Rodriguez L; Orre L; Klein E
Cancer Immunol Immunother; 1995 Oct; 41(4):217-26. PubMed ID: 7489564
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
9. Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer lines.
Calvo F; Jabrane N; Faille A; Gauville C; de Cremoux P; Lagier G; Abita JP; Lechat P
Int J Immunopharmacol; 1987; 9(4):459-68. PubMed ID: 3114155
[TBL] [Abstract][Full Text] [Related]
10. Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.
Sung CH; Hu CP; Hsu HC; Ng AK; Chou CK; Ting LP; Su TS; Han SH; Chang CM
J Clin Invest; 1989 Feb; 83(2):421-9. PubMed ID: 2536398
[TBL] [Abstract][Full Text] [Related]
11. Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon.
Bao SS; King NJ; dos Remedios CG
Immunol Cell Biol; 1990 Aug; 68 ( Pt 4)():235-41. PubMed ID: 2123472
[TBL] [Abstract][Full Text] [Related]
12. Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
Rees RC; Mian S
Cancer Immunol Immunother; 1999 Oct; 48(7):374-81. PubMed ID: 10501850
[TBL] [Abstract][Full Text] [Related]
13. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
Adair SJ; Hogan KT
Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715
[TBL] [Abstract][Full Text] [Related]
14. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
Akbasak A; Oldfield EH; Saris SC
J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
[TBL] [Abstract][Full Text] [Related]
15. Immunological profiling of a panel of human ovarian cancer cell lines.
Carr TM; Adair SJ; Fink MJ; Hogan KT
Cancer Immunol Immunother; 2008 Jan; 57(1):31-42. PubMed ID: 17579858
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of MHC class I expression in 3LL tumour cells.
Benihoud K; Lecerf JM; Bobé P; Kiger N
Eur J Immunogenet; 1991; 18(5-6):355-65. PubMed ID: 1772880
[TBL] [Abstract][Full Text] [Related]
17. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
18. The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells.
Morris AG; Darley RL; Bateman WJ
Cancer Immunol Immunother; 1992; 35(1):46-52. PubMed ID: 1611622
[TBL] [Abstract][Full Text] [Related]
19. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
20. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
